MDLN - Medline Inc.

Kaplan Fox Urges Medline Inc. (MDLN) Investors to Contact the Firm About Possible Securities Law Violations

New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Sep 08, 2026 02:20 PM • newsfilecorp.com

Nykredit A S Acquires New Holdings in Medline $MDLN

Nykredit A S purchased a new stake in Medline (NASDAQ: MDLN) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 36,116 shares of the company's stock, valued at approximately $1,424,000. A number of other hedge funds and

Sep 08, 2026 12:02 AM • defenseworld.net

H&F Corporate Investors X Ltd. Sells 15,599,171 Shares of Medline $MDLN

H&F Corporate Investors X Ltd. reduced its position in shares of Medline (NASDAQ: MDLN) by 18.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 70,874,326 shares of the company's stock after selling 15,599,171 shares during the period. Medline comprises

Sep 07, 2026 12:28 AM • defenseworld.net

Kaplan Fox & Kilsheimer LLP Alerts Investors of Medline Inc. (MDLN) to an Investigation of Potential Securities Law Violations

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Sep 04, 2026 06:00 AM • newsfilecorp.com

Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference

NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, on Tuesday, September 15, 2026, at 12:20pm ET.

Sep 03, 2026 04:30 AM • globenewswire.com

Kaplan Fox Notifies Medline Inc. (MDLN) Investors of a Securities Investigation into the Company

New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Sep 02, 2026 08:15 AM • newsfilecorp.com

Kaplan Fox & Kilsheimer LLP Announces an Investigation into Medline Inc. (MDLN) for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 31, 2026 07:30 AM • newsfilecorp.com

Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 28, 2026 07:15 AM • newsfilecorp.com (Hide legal announcements)

Kaplan Fox Alerts Medline Inc. (MDLN) Investors to an Investigation of Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 26, 2026 06:30 AM • newsfilecorp.com

Kaplan Fox Announces a Securities Investigation into Medline Inc. (MDLN) - Investors Encouraged to Contact the Firm

New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 24, 2026 08:45 AM • newsfilecorp.com (Hide legal announcements)

Kaplan Fox Encourages Investors of Medline Inc. (MDLN) to Contact the Firm to Learn About Their Legal Rights

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 21, 2026 01:30 PM • newsfilecorp.com (Hide legal announcements)

MDLN INVESTIGATION: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

Aug 21, 2026 04:26 AM • globenewswire.com (Hide legal announcements)

Kaplan Fox is Investigating Medline Inc. (MDLN) for Potential Violations of the Federal Securities Laws

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 19, 2026 11:30 AM • newsfilecorp.com

MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 18, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

Aug 18, 2026 03:54 PM • prnewswire.com (Hide legal announcements)

Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 17, 2026 10:00 AM • newsfilecorp.com

Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

Aug 17, 2026 09:38 AM • globenewswire.com (Hide legal announcements)

Kaplan Fox Reminds Medline Inc. (MDLN) Investors of an Investigation into Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 14, 2026 08:30 AM • newsfilecorp.com

MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 13, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

Aug 13, 2026 02:40 PM • prnewswire.com (Hide legal announcements)

MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

Aug 12, 2026 10:32 AM • globenewswire.com (Hide legal announcements)

Kaplan Fox is Investigating Medline Inc. (MDLN) on Behalf of Investors for Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Aug 12, 2026 08:00 AM • newsfilecorp.com

BTIG Reiterates Buy Rating on Medline Inc (MDLN)

$55.00 (was $34.58)

David Larsen · BTIG

Aug 27, 2026 05:09 AM • StreetInsider

Medline price target lowered to $42 from $45 at Bairdq

$42.00 (was $35.30)

Eric Coldwell · Robert W. Baird

Aug 06, 2026 09:23 AM • TheFly

Medline price target lowered to $39 from $48 at Evercore ISI

$39.00 (was $35.71)

Evercore ISI

Aug 06, 2026 08:51 AM • TheFly

Medline price target lowered to $45 from $50 at Stifel

$45.00 (was $35.54)

Stifel Nicolaus

Aug 06, 2026 08:30 AM • TheFly

Medline price target lowered to $47 from $54 at BMO Capital

$47.00 (was $36.66)

Sean Dodge · BMO Capital

Aug 06, 2026 07:31 AM • TheFly

Medline price target lowered to $46 from $53 at RBC Capital

$46.00 (was $36.66)

RBC Capital

Aug 06, 2026 07:05 AM • TheFly

Medline price target lowered to $37 from $42 at Deutsche Bank

$37.00 (was $36.66)

Deutsche Bank

Aug 06, 2026 04:19 AM • TheFly

Medline price target lowered to $45 from $57 at Baird

$45.00 (was $33.19)

Eric Coldwell · Robert W. Baird

Jun 03, 2026 06:39 AM • TheFly

Medline price target lowered to $45 from $50 at Barclays

$45.00 (was $36.56)

Glen Santangelo · Barclays

Jun 01, 2026 06:05 AM • TheFly

Medline price target lowered to $42 from $48 at Deutsche Bank

$42.00 (was $41.95)

Deutsche Bank

May 07, 2026 08:41 AM • TheFly

Medline price target raised to $60 from $55 at Tigress Financial

$60.00 (was $43.41)

Ivan Feinseth · Tigress Financial

Mar 09, 2026 08:03 AM • TheFly

Medline price target raised to $56 from $48 at Leerink

$56.00 (was $48.18)

Michael Cherny · Leerink Partners

Feb 25, 2026 02:48 PM • TheFly

Medline price target raised to $55 from $46 at Stifel

$55.00 (was $48.18)

Stifel Nicolaus

Feb 25, 2026 02:45 PM • TheFly

Medline price target raised to $55 from $50 at Evercore ISI

$55.00 (was $49.38)

Evercore ISI

Feb 25, 2026 01:37 PM • TheFly

Medline initiated with a Buy at Tigress Financial

$55.00 (was $45.01)

Tigress Financial

Feb 05, 2026 09:47 AM • TheFly

Medline price target raised to $55 from $50 at BTIG

$55.00 (was $43.16)

David Larsen · J.P. Morgan

Jan 21, 2026 07:16 AM • TheFly

Medline initiated with an Overweight at Barclays

$50.00 (was $41.65)

Barclays

Jan 12, 2026 08:39 AM • TheFly

Medline initiated with a Neutral at BNP Paribas

$38.00 (was $42.19)

BNP Paribas

Jan 12, 2026 08:17 AM • TheFly

Medline initiated with an Outperform at Wolfe Research

$47.00 (was $41.88)

Wolfe Research

Jan 12, 2026 07:53 AM • TheFly

Medline initiated with a Hold at Deutsche Bank

$40.00 (was $40.52)

Deutsche Bank

Jan 12, 2026 07:42 AM • TheFly